Search Results

A team of investigators at City of Hope funded by the Prostate Cancer Foundation reports that patients with advanced prostate cancer can be safely treated with chimeric antigen receptor T cell therapy.

The Rare Cancer Research Foundation is proud to announce an exciting collaboration with Spanios aimed at propelling the discovery and validation of groundbreaking therapeutic options for rare cancers.

The Lung Cancer Research Foundation (LCRF) has announced three research grant awards funded by Daiichi Sankyo and AstraZeneca, totaling $810,000.

The Pediatric Cancer Research Foundation, a nonprofit focused on transforming pediatric cancer care by funding research breakthroughs, announced the expansion of its leadership team.

Debbie’s Dream Foundation: Curing Stomach Cancer announces an unprecedented collaboration with Memorial Sloan Kettering Cancer Center that marks a significant leap forward in the field of gastric cancer research.

The Lung Cancer Research Foundation is pleased to announce Dr. Mark G. Kris as its honoree for the 3rd annual Evening of Innovation Gala, which will be held on September 24, 2024 at the Metropolitan Club in Manhattan.

Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, detailed data presented by its partners at the University of California, San Francisco on foundational prostate cancer antigen research utilized to inform the development of its mRNA drug candidate, NTX-470.